The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin

Interindividual variation in response to metformin, first-line therapy for type 2 diabetes, is substantial. Given that transporters are determinants of metformin pharmacokinetics, we examined the effects of promoter variants in both multidrug and toxin extrusion protein 1 (MATE1) (g.−66T→C, rs225228...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Stocker, Sophie L., Morrissey, Kari M., Yee, Sook Wah, Castro, Richard A., Xu, Lu, Dahlin, Amber, Ramirez, Andrea H., Roden, Dan M., Wilke, Russ A., McCarty, Cathy A., Davis, Robert L., Brett, Claire M., Giacomini, Kathleen M.
Формат: Artigo
Язык:Inglês
Опубликовано: 2012
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671611/
https://ncbi.nlm.nih.gov/pubmed/23267855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2012.210
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы